vs

Side-by-side financial comparison of OHIO VALLEY BANC CORP (OVBC) and AVITA Medical, Inc. (RCEL). Click either name above to swap in a different company.

AVITA Medical, Inc. is the larger business by last-quarter revenue ($17.6M vs $16.2M, roughly 1.1× OHIO VALLEY BANC CORP). OHIO VALLEY BANC CORP runs the higher net margin — 24.4% vs -66.0%, a 90.4% gap on every dollar of revenue. On growth, AVITA Medical, Inc. posted the faster year-over-year revenue change (-4.3% vs -4.6%). OHIO VALLEY BANC CORP produced more free cash flow last quarter ($17.0M vs $-6.1M). Over the past eight quarters, AVITA Medical, Inc.'s revenue compounded faster (26.0% CAGR vs 4.3%).

Valley National Bank of Arizona was a bank based in Phoenix, Arizona, founded in 1900 and acquired by Bank One in 1992. The bank was one of Arizona's leading financial institutions during the 20th century and the last major independent bank in Arizona at the time of its acquisition.

Avita Medical is a clinical and commercial company developing and marketing a range regenerative medicine products. The first regenerative medicine product brought to the market by Avita Medical was ReCell spray-on skin for the treatment of burns. The two latest products are ReNovaCell, for Aesthetics and Plastic applications including skin trauma, and ReGenerCell for the treatment of chronic wounds. The Avita Medical regenerative product range is currently marketed in Europe, the Middle East...

OVBC vs RCEL — Head-to-Head

Bigger by revenue
RCEL
RCEL
1.1× larger
RCEL
$17.6M
$16.2M
OVBC
Growing faster (revenue YoY)
RCEL
RCEL
+0.4% gap
RCEL
-4.3%
-4.6%
OVBC
Higher net margin
OVBC
OVBC
90.4% more per $
OVBC
24.4%
-66.0%
RCEL
More free cash flow
OVBC
OVBC
$23.2M more FCF
OVBC
$17.0M
$-6.1M
RCEL
Faster 2-yr revenue CAGR
RCEL
RCEL
Annualised
RCEL
26.0%
4.3%
OVBC

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
OVBC
OVBC
RCEL
RCEL
Revenue
$16.2M
$17.6M
Net Profit
$4.0M
$-11.6M
Gross Margin
81.2%
Operating Margin
30.7%
-59.1%
Net Margin
24.4%
-66.0%
Revenue YoY
-4.6%
-4.3%
Net Profit YoY
57.3%
-0.3%
EPS (diluted)
$-0.37

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
OVBC
OVBC
RCEL
RCEL
Q4 25
$16.2M
$17.6M
Q3 25
$16.3M
$17.1M
Q2 25
$17.4M
$18.4M
Q1 25
$16.8M
$18.5M
Q4 24
$17.0M
$18.4M
Q3 24
$15.4M
$19.5M
Q2 24
$14.7M
$15.2M
Q1 24
$14.9M
$11.1M
Net Profit
OVBC
OVBC
RCEL
RCEL
Q4 25
$4.0M
$-11.6M
Q3 25
$3.0M
$-13.2M
Q2 25
$4.2M
$-9.9M
Q1 25
$4.4M
$-13.9M
Q4 24
$2.5M
$-11.6M
Q3 24
$2.7M
$-16.2M
Q2 24
$3.0M
$-15.4M
Q1 24
$2.8M
$-18.7M
Gross Margin
OVBC
OVBC
RCEL
RCEL
Q4 25
81.2%
Q3 25
81.3%
Q2 25
81.2%
Q1 25
84.7%
Q4 24
87.6%
Q3 24
83.7%
Q2 24
86.1%
Q1 24
86.4%
Operating Margin
OVBC
OVBC
RCEL
RCEL
Q4 25
30.7%
-59.1%
Q3 25
22.9%
-53.6%
Q2 25
29.8%
-60.5%
Q1 25
33.1%
-63.9%
Q4 24
18.1%
-54.1%
Q3 24
21.3%
-70.6%
Q2 24
24.7%
-102.8%
Q1 24
22.8%
-155.0%
Net Margin
OVBC
OVBC
RCEL
RCEL
Q4 25
24.4%
-66.0%
Q3 25
18.5%
-77.3%
Q2 25
24.2%
-53.9%
Q1 25
26.2%
-74.9%
Q4 24
14.8%
-63.0%
Q3 24
17.6%
-82.9%
Q2 24
20.3%
-101.3%
Q1 24
18.8%
-168.0%
EPS (diluted)
OVBC
OVBC
RCEL
RCEL
Q4 25
$-0.37
Q3 25
$-0.46
Q2 25
$-0.38
Q1 25
$-0.53
Q4 24
$-0.44
Q3 24
$-0.62
Q2 24
$-0.60
Q1 24
$-0.73

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
OVBC
OVBC
RCEL
RCEL
Cash + ST InvestmentsLiquidity on hand
$45.9M
$18.2M
Total DebtLower is stronger
Stockholders' EquityBook value
$170.3M
$-16.6M
Total Assets
$1.6B
$56.4M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
OVBC
OVBC
RCEL
RCEL
Q4 25
$45.9M
$18.2M
Q3 25
$89.3M
$23.3M
Q2 25
$54.6M
$15.7M
Q1 25
$120.6M
$25.8M
Q4 24
$83.1M
$35.9M
Q3 24
$82.2M
$44.4M
Q2 24
$107.7M
$54.1M
Q1 24
$129.1M
$68.2M
Stockholders' Equity
OVBC
OVBC
RCEL
RCEL
Q4 25
$170.3M
$-16.6M
Q3 25
$164.4M
$-6.7M
Q2 25
$160.8M
$-12.9M
Q1 25
$155.7M
$-4.6M
Q4 24
$150.3M
$4.5M
Q3 24
$152.2M
$12.2M
Q2 24
$145.8M
$23.9M
Q1 24
$145.8M
$32.6M
Total Assets
OVBC
OVBC
RCEL
RCEL
Q4 25
$1.6B
$56.4M
Q3 25
$1.6B
$63.7M
Q2 25
$1.5B
$58.1M
Q1 25
$1.5B
$69.6M
Q4 24
$1.5B
$79.7M
Q3 24
$1.5B
$81.1M
Q2 24
$1.4B
$87.8M
Q1 24
$1.4B
$97.4M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
OVBC
OVBC
RCEL
RCEL
Operating Cash FlowLast quarter
$18.1M
$-5.4M
Free Cash FlowOCF − Capex
$17.0M
$-6.1M
FCF MarginFCF / Revenue
105.2%
-34.7%
Capex IntensityCapex / Revenue
6.4%
3.8%
Cash ConversionOCF / Net Profit
4.57×
TTM Free Cash FlowTrailing 4 quarters
$26.5M
$-33.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
OVBC
OVBC
RCEL
RCEL
Q4 25
$18.1M
$-5.4M
Q3 25
$5.3M
$-5.2M
Q2 25
$4.5M
$-10.2M
Q1 25
$496.0K
$-10.3M
Q4 24
$13.1M
$-8.1M
Q3 24
$5.6M
$-7.2M
Q2 24
$4.2M
$-12.8M
Q1 24
$928.0K
$-20.9M
Free Cash Flow
OVBC
OVBC
RCEL
RCEL
Q4 25
$17.0M
$-6.1M
Q3 25
$5.0M
$-6.2M
Q2 25
$4.4M
$-10.8M
Q1 25
$138.0K
$-10.5M
Q4 24
$11.7M
$-9.7M
Q3 24
$5.4M
$-11.0M
Q2 24
$3.9M
$-15.4M
Q1 24
$234.0K
$-22.0M
FCF Margin
OVBC
OVBC
RCEL
RCEL
Q4 25
105.2%
-34.7%
Q3 25
30.4%
-36.1%
Q2 25
25.1%
-58.4%
Q1 25
0.8%
-56.9%
Q4 24
68.7%
-52.7%
Q3 24
35.1%
-56.1%
Q2 24
26.3%
-101.6%
Q1 24
1.6%
-198.2%
Capex Intensity
OVBC
OVBC
RCEL
RCEL
Q4 25
6.4%
3.8%
Q3 25
2.1%
5.5%
Q2 25
0.6%
2.8%
Q1 25
2.1%
1.2%
Q4 24
8.4%
8.8%
Q3 24
1.2%
19.2%
Q2 24
2.2%
17.5%
Q1 24
4.7%
10.3%
Cash Conversion
OVBC
OVBC
RCEL
RCEL
Q4 25
4.57×
Q3 25
1.75×
Q2 25
1.06×
Q1 25
0.11×
Q4 24
5.21×
Q3 24
2.06×
Q2 24
1.41×
Q1 24
0.33×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons